Show simple item record

dc.contributor.authorZhilyaev, S. Yu.
dc.contributor.authorPlatonova, T. F.
dc.contributor.authorKhlebnikov, A. I.
dc.contributor.authorDemchenko, I. T.
dc.contributor.authorAtochin, D. N.
dc.date.accessioned2023-08-09T21:16:44Z
dc.date.available2023-08-09T21:16:44Z
dc.date.issued2023-05
dc.identifier.citationZhilyaev, S.Y., Platonova, T.F., Khlebnikov, A.I. et al. Vasoactive and Neuroprotective Effects of c-Jun N-Terminal Kinase Inhibitor in Rats with Chronic Cerebral Hypoperfusion. J Evol Biochem Phys 59, 951–959 (2023). https://doi.org/10.1134/S0022093023030262en_US
dc.identifier.issn0022-0930
dc.identifier.urihttps://scholarworks.montana.edu/xmlui/handle/1/18062
dc.descriptioncopyright Pleiades Publishing Ltd 2023en_US
dc.description.abstractThe aim of this study was to evaluate the vasoactive and neuroprotective effects of c-Jun N-terminal kinase inhibitor IQ-1 (11H-indeno[1,2-b]quinoxalin-11-one oxime) in chronic cerebral hypoperfusion caused by irreversible bilateral common carotid artery ligation [two-vessel occlusion (2VO) model]. Cerebral blood flow was measured quantitatively (hydrogen clearance method) simultaneously in the parietal cortex, hippocampus, substantia nigra, and striatum of the brain of awake rats. It was found that 2VO caused a decrease in blood flow in the brain regions with a more pronounced decrease in the cortex (by 48% of the initial level) and with a minimum drop in the substantia nigra (by 25% of the initial level). The reduced level of blood flow persisted for 14 days of measurements. The responses of the cerebral vessels to hypercapnic probes (5% CO2) were lost during the 2-week hypoperfusion period, and the neurological status of the animals did not improve. The administration of IQ-1 (50 mg/kg, intraperitoneally, every 48 h for 14 days) was accompanied by an increase in blood flow in all brain regions. A maximum increase in blood flow was observed in the striatum and a minimum in the substantia nigra. After the administration of IQ-1, the sensitivity of the cerebral vessels to the hypercapnic stimulus was restored, and the neurological state of the animals significantly improved by the end of the second week of cerebral hypoperfusion. The results show that the use of the JNK inhibitor can reduce cerebrovascular disorders and related neurological disorders in hypoperfusion brain injury.en_US
dc.language.isoen_USen_US
dc.publisherPleiades Publishing Ltden_US
dc.rightscopyright Pleiades Publishing Ltd 2023en_US
dc.rights.urihttps://web.archive.org/web/20200211115833/https://www.pleiades.online//en/journals/permission/en_US
dc.subjectc-Jun N-terminal kinase inhibitoren_US
dc.subjectchronic cerebral hypoperfusionen_US
dc.subjectcerebral blood flowen_US
dc.subjectneuroprotectionen_US
dc.subjecthypercapnic probeen_US
dc.subjectstriatumen_US
dc.subjectsubstantia nigraen_US
dc.titleVasoactive and Neuroprotective Effects of c-Jun N-Terminal Kinase Inhibitor in Rats with Chronic Cerebral Hypoperfusionen_US
dc.typeArticleen_US
mus.citation.extentfirstpage1en_US
mus.citation.extentlastpage9en_US
mus.citation.issue3en_US
mus.citation.journaltitleJournal of Evolutionary Biochemistry and Physiologyen_US
mus.citation.volume59en_US
mus.identifier.doi10.1134/S0022093023030262en_US
mus.relation.collegeCollege of Agricultureen_US
mus.relation.departmentMicrobiology & Immunology.en_US
mus.relation.universityMontana State University - Bozemanen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record


MSU uses DSpace software, copyright © 2002-2017  Duraspace. For library collections that are not accessible, we are committed to providing reasonable accommodations and timely access to users with disabilities. For assistance, please submit an accessibility request for library material.